{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:52:13Z","timestamp":1793397133591,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10142-023-01075-3","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T07:02:09Z","timestamp":1683270129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["SORL1 stabilizes ABCB1 to promote cisplatin resistance in ovarian cancer"],"prefix":"10.1007","volume":"23","author":[{"given":"Zhen","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QinYang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yincheng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"1075_CR1","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41388-020-01604-5","volume":"40","author":"H Al-Akhrass","year":"2021","unstructured":"Al-Akhrass H, Conway JRW, Poulsen ASA, Paatero I, Kaivola J, Padzik A, Andersen OM, Jl I (2021) A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance. Oncogene 40:1300\u20131317","journal-title":"Oncogene"},{"key":"1075_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1083\/jcb.201411045","volume":"210","author":"AO Bamidele","year":"2015","unstructured":"Bamidele AO, Kremer KN, Hirsova P, Clift IC, Gores GJ, Billadeau DD, KEl H (2015) IQGAP1 promotes CXCR4 chemokine receptor function and trafficking via EEA-1+ endosomes. J Cell Biol 210:257\u2013272","journal-title":"J Cell Biol"},{"key":"1075_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-019-01991-4","volume":"138","author":"D Campion","year":"2019","unstructured":"Campion D, Charbonnier C, Gl N (2019) SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data. Acta Neuropathol 138:173\u2013186","journal-title":"Acta Neuropathol"},{"key":"1075_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2018.09.032","volume":"840","author":"M Cheng","year":"2018","unstructured":"Cheng M, Cai W, Huang W, Chen Y, Wu Z, Luo P, Wl Y (2018) Histone deacetylase 6 regulated expression of IL-8 is involved in the doxorubicin (Dox) resistance of osteosarcoma cells via modulating ABCB1 transcription. Eur J Pharmacol 840:1\u20138","journal-title":"Eur J Pharmacol"},{"key":"1075_CR5","doi-asserted-by":"publisher","first-page":"viii13","DOI":"10.1093\/annonc\/mdx446","volume":"28","author":"EL Christie","year":"2017","unstructured":"Christie EL, DDLl B (2017) Acquired chemotherapy resistance in ovarian cancer. Ann Oncol 28:viii13\u2013vviii5","journal-title":"Ann Oncol"},{"key":"1075_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.024","volume":"513","author":"M Dai","year":"2021","unstructured":"Dai M, Yang B, Chen J, Liu F, Zhou Y, Zhou Y, Xu Q, Jiang S, Zhao S, Li X, Zhou X, Yang Q, Li J, Wang Y, Zhang Z, Yl T (2021) Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer. Cancer Lett 513:36\u201349","journal-title":"Cancer Lett"},{"key":"1075_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/cancers11010119","volume":"11","author":"G Damia","year":"2019","unstructured":"Damia G, Ml B (2019) Platinum Resistance in Ovarian Cancer: Role of DNA Repair. Cancers (Basel) 11:119","journal-title":"Cancers (Basel)"},{"key":"1075_CR8","doi-asserted-by":"publisher","first-page":"e47734","DOI":"10.15252\/embr.201947734","volume":"20","author":"J Fraser","year":"2019","unstructured":"Fraser J, Simpson J, Fontana R, Kishi-Itakura C, Ktistakis NT, Nl G (2019) Targeting of early endosomes by autophagy facilitates EGFR recycling and signalling. EMBO Rep 20:e47734","journal-title":"EMBO Rep"},{"key":"1075_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.biocel.2011.12.009","volume":"44","author":"D Fu","year":"2012","unstructured":"Fu D, IMl A (2012) Intracellular trafficking of P-glycoprotein. Int J Biochem Cell Biol 44:461\u2013464","journal-title":"Int J Biochem Cell Biol"},{"key":"1075_CR10","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1016\/j.ymthe.2022.06.015","volume":"30","author":"LP Hu","year":"2022","unstructured":"Hu LP, Huang W, Wang X, Xu C, Qin WT, Li D, Tian G, Li Q, Zhou Y, Chen S, Nie HZ, Hao Y, Song J, Zhang XL, Sundquist J, Sundquist K, Li J, Jiang SH, Zhang ZG, Jl J (2022) Terbinafine prevents colorectal cancer growth by inducing dNTP starvation and reducing immune suppression. Mol Ther 30:3284\u20133299","journal-title":"Mol Ther"},{"key":"1075_CR11","doi-asserted-by":"publisher","first-page":"e13237","DOI":"10.1111\/cpr.13237","volume":"55","author":"Y Huo","year":"2022","unstructured":"Huo Y, Yang J, Zheng J, Xu D, Yang M, Tao L, Yao H, Fu X, Yang J, Liu D, Hua R, Zhang J, Sun Y, Hu L, Wl L (2022) Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling. Cell Prolif 55:e13237","journal-title":"Cell Prolif"},{"key":"1075_CR12","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1136\/gutjnl-2018-317479","volume":"68","author":"SH Jiang","year":"2019","unstructured":"Jiang SH, Zhu LL, Zhang M, Li RK, Yang Q, Yan JY, Zhang C, Yang JY, Dong FY, Dai M, Hu LP, Li J, Li Q, Wang YH, Yang XM, Zhang YL, Nie HZ, Zhu L, Zhang XL, Tian GA, Zhang XX, Cao XY, Tao LY, Huang S, Jiang YS, Hua R, Qian Luo K, Gu JR, Sun YW, Hou S, Zhang ZGl (2019) GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner. Gut 68:1994\u20132006","journal-title":"Gut"},{"key":"1075_CR13","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.bbamcr.2015.06.001","volume":"1853","author":"K Katayama","year":"2015","unstructured":"Katayama K, Kapoor K, Ohnuma S, Patel A, Swaim W, Ambudkar IS, SVl A (2015) Revealing the fate of cell surface human P-glycoprotein (ABCB1): The lysosomal degradation pathway. Biochim Biophys Acta 1853:2361\u20132370","journal-title":"Biochim Biophys Acta"},{"key":"1075_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41419-022-04568-4","volume":"13","author":"JY Kim","year":"2022","unstructured":"Kim JY, Bahar E, Lee JY, Chang S, Kim SH, Park EY, Do SI, Yoon H, HSl K (2022) ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma. Cell Death Dis 13:239","journal-title":"Cell Death Dis"},{"key":"1075_CR15","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1200\/JCO.19.02960","volume":"38","author":"PA Konstantinopoulos","year":"2020","unstructured":"Konstantinopoulos PA, Norquist B, Lacchetti C, Armstrong D, Grisham RN, Goodfellow PJ, Kohn EC, Levine DA, Liu JF, Lu KH, Sparacio D, CMl A (2020) Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline. J Clin Oncol 38:1222\u20131245","journal-title":"J Clin Oncol"},{"key":"1075_CR16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, AMl O (2019) Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J Clin 69:280\u2013304","journal-title":"CA Cancer J Clin"},{"key":"1075_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","volume":"27","author":"W Li","year":"2016","unstructured":"Li W, Zhang H, Assaraf YG, Zhao K, Xu X, Xie J, Yang DH, ZSl C (2016) Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies. Drug Resist Updat 27:14\u201329","journal-title":"Drug Resist Updat"},{"key":"1075_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","volume":"77","author":"C Marchetti","year":"2021","unstructured":"Marchetti C, De Felice F, Romito A, Iacobelli V, Sassu CM, Corrado G, Ricci C, Scambia G, Al F (2021) Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments. Semin Cancer Biol 77:144\u2013166","journal-title":"Semin Cancer Biol"},{"key":"1075_CR19","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1038\/s41467-021-24009-8","volume":"12","author":"EA Pietila","year":"2021","unstructured":"Pietila EA, Gonzalez-Molina J, Moyano-Galceran L, Jamalzadeh S, Zhang K, Lehtinen L, Turunen SP, Martins TA, Gultekin O, Lamminen T, Kaipio K, Joneborg U, Hynninen J, Hietanen S, Grenman S, Lehtonen R, Hautaniemi S, Carpen O, Carlson JW, Kl L (2021) Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance. Nat Commun 12:3904","journal-title":"Nat Commun"},{"key":"1075_CR20","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1038\/s41467-019-10275-0","volume":"10","author":"M Pietila","year":"2019","unstructured":"Pietila M, Sahgal P, Peuhu E, Jantti NZ, Paatero I, Narva E, Al-Akhrass H, Lilja J, Georgiadou M, Andersen OM, Padzik A, Sihto H, Joensuu H, Blomqvist M, Saarinen I, Bostrom PJ, Taimen P, Jl I (2019) SORLA regulates endosomal trafficking and oncogenic fitness of HER2. Nat Commun 10:2340","journal-title":"Nat Commun"},{"key":"1075_CR21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3332\/ecancer.2017.768","volume":"11","author":"D Pokharel","year":"2017","unstructured":"Pokharel D, Roseblade A, Oenarto V, Lu JF, Ml B (2017) Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer. Ecancermedicalscience 11:768","journal-title":"Ecancermedicalscience"},{"key":"1075_CR22","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00018-016-2410-z","volume":"74","author":"V Schmidt","year":"2017","unstructured":"Schmidt V, Subkhangulova A, TEl W (2017) Sorting receptor SORLA: cellular mechanisms and implications for disease. Cell Mol Life Sci 74:1475\u20131483","journal-title":"Cell Mol Life Sci"},{"key":"1075_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Al J (2021) Cancer Statistics, 2021. CA Cancer J Clin 71:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"1075_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Al J (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"1075_CR25","doi-asserted-by":"publisher","first-page":"5908","DOI":"10.1523\/JNEUROSCI.0723-20.2020","volume":"40","author":"J Stupack","year":"2020","unstructured":"Stupack J, Xiong XP, Jiang LL, Zhang T, Zhou L, Campos A, Ranscht B, Mobley W, Pasquale EB, Xu H, TYl H (2020) Soluble SORLA Enhances Neurite Outgrowth and Regeneration through Activation of the EGF Receptor\/ERK Signaling Axis. J Neurosci 40:5908\u20135921","journal-title":"J Neurosci"},{"key":"1075_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Fl B (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"1075_CR27","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3389\/fphar.2018.01507","volume":"9","author":"H Talbot","year":"2018","unstructured":"Talbot H, Saada S, Naves T, Gallet PF, Fauchais AL, MOl J (2018) Regulatory Roles of Sortilin and SorLA in Immune-Related Processes. Front Pharmacol 9:1507","journal-title":"Front Pharmacol"},{"key":"1075_CR28","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1080\/15548627.2022.2040314","volume":"18","author":"KKL Wu","year":"2022","unstructured":"Wu KKL, Cheng KKY (2022) A new role of the early endosome in restricting NLRP3 inflammasome via mitophagy. Autophagy 18:1475\u20131477","journal-title":"Autophagy"},{"key":"1075_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1124\/mol.109.061713","volume":"78","author":"Y Xie","year":"2010","unstructured":"Xie Y, Burcu M, Linn DE, Qiu Y, MRl B (2010) Pim-1 kinase protects P-glycoprotein from degradation and enables its glycosylation and cell surface expression. Mol Pharmacol 78:310\u2013318","journal-title":"Mol Pharmacol"},{"key":"1075_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3892\/or.2016.5230","volume":"37","author":"YY Yan","year":"2017","unstructured":"Yan YY, Wang F, Zhao XQ, Wang XK, Chen YF, Liu H, Xie Y, LWl F (2017) Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro. Oncol Rep 37:31\u201340","journal-title":"Oncol Rep"},{"key":"1075_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2021.05.016","volume":"515","author":"B Yang","year":"2021","unstructured":"Yang B, Chen J, Li X, Zhang X, Hu L, Jiang S, Zhang Z, Yl T (2021) TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer. Cancer Lett 515:14\u201327","journal-title":"Cancer Lett"},{"key":"1075_CR32","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1038\/s41388-020-1384-3","volume":"39","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Liu F, Xu Q, Yang B, Li X, Jiang S, Hu L, Zhang X, Zhu L, Li Q, Zhu X, Shao H, Dai M, Shen Y, Ni B, Wang S, Zhang Z, Yl T (2020) Inhibiting Importin 4-mediated nuclear import of CEBPD enhances chemosensitivity by repression of PRKDC-driven DNA damage repair in cervical cancer. Oncogene 39:5633\u20135648","journal-title":"Oncogene"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-023-01075-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-023-01075-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-023-01075-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T04:11:11Z","timestamp":1702354271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-023-01075-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1007\/s10142-023-01075-3","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"147"}}